These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Isoform-specific regulation of nitric oxide synthase mRNA in the kidney by sodium and blood pressure. Nadaud S; Mao C; Luvàra G; Michel JB; Soubrier F J Hypertens; 1998 Sep; 16(9):1315-23. PubMed ID: 9746119 [TBL] [Abstract][Full Text] [Related]
4. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats. Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177 [TBL] [Abstract][Full Text] [Related]
5. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats. Silambarasan T; Raja B Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490 [TBL] [Abstract][Full Text] [Related]
7. Increased nitric oxide synthase-3 expression in kidneys of deoxycorticosterone acetate-salt hypertensive rats. Allcock GH; Hukkanen M; Polak JM; Pollock JS; Pollock DM J Am Soc Nephrol; 1999 Nov; 10(11):2283-9. PubMed ID: 10541286 [TBL] [Abstract][Full Text] [Related]
8. Depressor effects of captopril in DOCA-salt hypertensive rats: role of vasopressin. Igarashi Y; Suzuki H; Itaya Y; Kondo K; Saruta T J Hypertens; 1985 Apr; 3(2):149-53. PubMed ID: 3894513 [TBL] [Abstract][Full Text] [Related]
9. Effects of antihypertensive drugs on nitric oxide synthase activity in rat kidney. Tojo A; Kobayashi N; Kimura K; Hirata Y; Matsuoka H; Yagi S; Omata M Kidney Int Suppl; 1996 Jun; 55():S138-40. PubMed ID: 8743536 [TBL] [Abstract][Full Text] [Related]
10. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats. Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011 [TBL] [Abstract][Full Text] [Related]
11. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system. Brown L; Duce B; Miric G; Sernia C J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S143-8. PubMed ID: 9892155 [TBL] [Abstract][Full Text] [Related]
12. Glomerular expression of endothelial nitric oxide synthase in deoxycorticosterone acetate-salt-treated rats. Tsuchiya K; Naruse M; Nihei H Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):818-20. PubMed ID: 11022975 [TBL] [Abstract][Full Text] [Related]
13. (-)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats. Jackson D; Connolly K; Batacan R; Ryan K; Vella R; Fenning A Molecules; 2018 Jun; 23(7):. PubMed ID: 29932135 [TBL] [Abstract][Full Text] [Related]
14. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation. Prahalathan P; Kumar S; Raja B Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933 [TBL] [Abstract][Full Text] [Related]
15. Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist. Kubacka M; Zadrożna M; Nowak B; Kotańska M; Filipek B; Waszkielewicz AM; Marona H; Mogilski S Hypertens Res; 2019 Aug; 42(8):1125-1141. PubMed ID: 30872813 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats. Safaeian L; Emami R; Hajhashemi V; Haghighatian Z Biomed Pharmacother; 2018 Apr; 100():147-155. PubMed ID: 29428662 [TBL] [Abstract][Full Text] [Related]
17. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress. Bhatia J; Tabassum F; Sharma AK; Bharti S; Golechha M; Joshi S; Sayeed Akhatar M; Srivastava AK; Arya DS Cardiovasc Toxicol; 2011 Sep; 11(3):272-9. PubMed ID: 21748534 [TBL] [Abstract][Full Text] [Related]
18. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension. K-Laflamme A; Oster L; Cardinal R; de Champlain J Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405 [TBL] [Abstract][Full Text] [Related]
19. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats. Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815 [TBL] [Abstract][Full Text] [Related]
20. Long-term administration of L-arginine improves nitric oxide release from kidney in deoxycorticosterone acetate-salt hypertensive rats. Hayakawa H; Hirata Y; Suzuki E; Kimura K; Kikuchi K; Nagano T; Hirobe M; Omata M Hypertension; 1994 Jun; 23(6 Pt 1):752-6. PubMed ID: 8206573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]